SS

Sarla Singh

Active Director Director DIN 01559973
DIN 01559973 First appointment Jun 2003 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2003
Shareholding value •••• Premium profile

About Sarla Singh

Data last updated:

Sarla Singh is a Director at Krypton Biomedicals Private Limited (since 2003). The company operates in Healthcare. Krypton Biomedicals Private Limited reported revenue of ₹48.1 Lakh (FY 2025).

DIN 01559973
Primary Designation Director
Industry Healthcare
First Appointment 01 Jun 2003
Oldest Company Age 23 yrs
Largest company Krypton Biomedicals Private Limited · ₹48.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Krypton Biomedicals Private Limited U51397DL2003PTC119626
Director01 Jun 20032003₹48.1 Lakh (FY 2025)Active

Board colleagues of Sarla Singh

Directorship timeline

Open interactive timeline →
Krypton Biomedicals Private Limited
Premium access

Shareholding and investment profile for Sarla Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarla Singh

Sarla Singh currently holds 1 directorship: Krypton Biomedicals Private Limited (Director, since 01 Jun 2003, revenue ₹48.1 Lakh (FY 2025)).

Sarla Singh was first appointed on 01 Jun 2003 as Director at Krypton Biomedicals Private Limited.

The current boards of Sarla Singh's companies include Priyanka Rathi (Krypton Biomedicals Private Limited), Virendra Singh (Krypton Biomedicals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available